1
|
Dai X, Nie W, Duan C, Shen Y. Preparation of microspheres with sustained ketoprofen release by electrospray for the treatment of aseptic inflammation. Front Bioeng Biotechnol 2024; 12:1416659. [PMID: 39100621 PMCID: PMC11294161 DOI: 10.3389/fbioe.2024.1416659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2024] [Accepted: 06/27/2024] [Indexed: 08/06/2024] Open
Abstract
The treatment of aseptic inflammation has always been a clinical challenge. At present, non-steroidal drug-loaded microspheres have been widely used in the treatment of aseptic inflammation due to their excellent injectable and sustained release capabilities. In this study, ketoprofen-loaded shellac microspheres (Keto-SLAC) were prepared by electrospray. Alterations of Keto-SLAC morphology was observed in response to changed shellac concentration in ethanol solution through electrospray. Further examination revealed that ketoprofen presented as amorphous solid dispersion in the shellac microspheres. Most importantly, it was also shown that ketoprofen can be slowly released from the shellac matrix for up to 3 weeks. In vitro cell experiments verified that the microspheres had favorable cell compatibility. We therefore proposed that the prepared microspheres, being readily available in use in a variety of clinical settings through topical application, have promising therapeutic potential for the treatment of aseptic inflammation.
Collapse
Affiliation(s)
- Xinyi Dai
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Wei Nie
- Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| | | | - Yi Shen
- Bio-ID Center, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
2
|
Sarafska T, Ivanova S, Dudev T, Tzachev C, Petrov V, Spassov T. Enhanced Solubility of Ibuprofen by Complexation with β-Cyclodextrin and Citric Acid. Molecules 2024; 29:1650. [PMID: 38611930 PMCID: PMC11013186 DOI: 10.3390/molecules29071650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2024] [Revised: 03/31/2024] [Accepted: 04/03/2024] [Indexed: 04/14/2024] Open
Abstract
The ability of β-CD to form inclusion complexes with ibuprofen (IBU) and at the same time to make a two-phase system with citric acid was explored in the present study for achieving improved solubility and dissolution rate of IBU. Mechanical milling as well as mechanical milling combined with thermal annealing of the powder mixtures were applied as synthetic methods. Solubility and dissolution kinetics of the complexes were studied in compliance with European Pharmacopoeia (ICH Q4B). β-CD and citric acid (CA) molecules were shown to interact by both ball milling (BM), thermal annealing, as well as BM with subsequent annealing. Complexes were also formed by milling the three compounds (β-CD, CA and IBU) simultaneously, as well as by a consecutive first including IBU into β-CD and then binding the formed β-CD/IBU inclusion complex with CA. As a result, ternary β-CD/IBU/CA complex formed by initial incorporation of ibuprofen into β-CD, followed by successive formation of a two-phase mixture with CA, exhibited notably improved dissolution kinetics compared to the pure ibuprofen and slightly better compared to the binary β-CD/IBU system. Although the addition of CA to β-CD/IBU does not significantly increase the solubility rate of IBU, it must be considered that the amount of β-CD is significantly less in the ternary complex compared to the binary β-CD/IBU.
Collapse
Affiliation(s)
| | | | | | | | | | - Tony Spassov
- Faculty of Chemistry and Pharmacy, Sofia University “St. Kl. Ohridski”, 1164 Sofia, Bulgaria; (T.S.); (S.I.); (T.D.); (C.T.); (V.P.)
| |
Collapse
|
3
|
Simitopoulos A, Tsekouras A, Macheras P. Coupling Drug Dissolution with BCS. Pharm Res 2024; 41:481-491. [PMID: 38291164 DOI: 10.1007/s11095-024-03661-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Accepted: 01/15/2024] [Indexed: 02/01/2024]
Abstract
PURPOSE The purpose of this study is to develop a Temporal Biopharmaceutic Classification System (T-BCS), linking Finite Dissolution Time (F.D.T.) and Mean Dissolution Time (M.D.T.) for Class I/III drugs and Mean Dissolution Time for saturation (M.D.T.s.) for Class II/IV drugs. METHODS These parameters are estimated graphically or by fitting dissolution models to experimental data and coupled with the dose-to-solubility ratio (q) for each drug normalized in terms of the actual volume of dissolution medium (900 mL). RESULTS Class I/III drugs consistently exhibited q values less than 1, aligning with expectations based on their solubility, while some Class II/IV drugs presented a deviation from anticipated q values, with observations of q < 1. This irregularity was rendered to the dissolution volume of 250 mL used for biopharmaceutical classification purposes instead of 900 mL applied as well as the dual classification of some sparingly soluble drugs. Biowaivers were also analyzed in terms of M.D.T., F.D.T. estimates and the regulatory dissolution time limits for rapidly and very-rapidly dissolved drugs. CONCLUSIONS The T-BCS is useful for establishing correlations and assessing the magnitude of M.D.T., F.D.T., or M.D.T.s. for inter- and intra-class comparisons of different drugs and provide relationships between these parameters across all the models that were utilized.
Collapse
Affiliation(s)
- Antony Simitopoulos
- Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
| | - Athanasios Tsekouras
- Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece
- PharmaInformatics Unit, ATHENA Research Center, Athens, Greece
| | - Panos Macheras
- Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
- PharmaInformatics Unit, ATHENA Research Center, Athens, Greece.
| |
Collapse
|
4
|
Staniszewska M, Romański M, Polak S, Garbacz G, Dobosz J, Myslitska D, Romanova S, Paszkowska J, Danielak D. A Rational Approach to Predicting Immediate Release Formulation Behavior in Multiple Gastric Motility Patterns: A Combination of a Biorelevant Apparatus, Design of Experiments, and Machine Learning. Pharmaceutics 2023; 15:2056. [PMID: 37631270 PMCID: PMC10458881 DOI: 10.3390/pharmaceutics15082056] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Revised: 07/24/2023] [Accepted: 07/28/2023] [Indexed: 08/27/2023] Open
Abstract
Gastric mechanical stress often impacts drug dissolution from solid oral dosage forms, but in vitro experiments cannot recreate the substantial variability of gastric motility in a reasonable time. This study, for the first time, combines a novel dissolution apparatus with the design of experiments (DoE) and machine learning (ML) to overcome this obstacle. The workflow involves the testing of soft gelatin capsules in a set of fasted-state biorelevant dissolution experiments created with DoE. The dissolution results are used by an ML algorithm to build the classification model of the capsule's opening in response to intragastric stress (IS) within the physiological space of timing and magnitude. Next, a random forest algorithm is used to model the further drug dissolution. The predictive power of the two ML models is verified with independent dissolution tests, and they outperform a polynomial-based DoE model. Moreover, the developed tool reasonably simulates over 50 dissolution profiles under varying IS conditions. Hence, we prove that our method can be utilized for the simulation of dissolution profiles related to the multiplicity of individual gastric motility patterns. In perspective, the developed workflow can improve virtual bioequivalence trials and the patient-centric development of immediate-release oral dosage forms.
Collapse
Affiliation(s)
- Marcela Staniszewska
- Physiolution Polska, 74 Piłsudskiego St., 50-020 Wrocław, Poland; (G.G.); (J.D.); (D.M.); (S.R.); (J.P.)
| | - Michał Romański
- Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznań, Poland; (M.R.); (D.D.)
| | - Sebastian Polak
- Faculty of Pharmacy, Medical College, Jagiellonian University, Medyczna 9 Street, 30-688 Kraków, Poland;
| | - Grzegorz Garbacz
- Physiolution Polska, 74 Piłsudskiego St., 50-020 Wrocław, Poland; (G.G.); (J.D.); (D.M.); (S.R.); (J.P.)
| | - Justyna Dobosz
- Physiolution Polska, 74 Piłsudskiego St., 50-020 Wrocław, Poland; (G.G.); (J.D.); (D.M.); (S.R.); (J.P.)
| | - Daria Myslitska
- Physiolution Polska, 74 Piłsudskiego St., 50-020 Wrocław, Poland; (G.G.); (J.D.); (D.M.); (S.R.); (J.P.)
| | - Svitlana Romanova
- Physiolution Polska, 74 Piłsudskiego St., 50-020 Wrocław, Poland; (G.G.); (J.D.); (D.M.); (S.R.); (J.P.)
| | - Jadwiga Paszkowska
- Physiolution Polska, 74 Piłsudskiego St., 50-020 Wrocław, Poland; (G.G.); (J.D.); (D.M.); (S.R.); (J.P.)
| | - Dorota Danielak
- Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznań, Poland; (M.R.); (D.D.)
| |
Collapse
|
5
|
Ismanelly Hanum T, Nasution A, Sumaiyah S, Bangun H. Physical stability and dissolution of ketoprofen nanosuspension formulation: Polyvinylpyrrolidone and Tween 80 as stabilizers. PHARMACIA 2023. [DOI: 10.3897/pharmacia.70.e96593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Abstract
This study was conducted to improve the dissolution of ketoprofen in nanosuspensions. Ketoprofen nanosuspensions were prepared by a solvent evaporation method using polyvinylpyrrolidone (PVP) and Tween 80 as stabilizers at varied ratios with ketoprofen. Ethanol was used as a solvent for ketoprofen. Physical stability and dissolution of the produced ketoprofen nanosuspensions and conventional suspension were analyzed and compared. The parameters evaluated for their stability for a three-month period were pH, appearance, odor, color, particle size, zeta potential, polydispersity index (PI), and dissolution compared with ketoprofen suspension. Ketoprofen and PVP ratios of 1:1 and 1:1.5 had nano-scale particle sizes of 78.47±0.61 and 156.9±1.55, respectively. These nanosuspensions had stable pH, appearance, odor, color, particle size, and PI at room temperature. The dissolution rates of ketoprofen nanosuspensions were higher compared to that of ketoprofen conventional suspension. PVP and Tween 80 improved ketoprofen nanosuspension dissolution and was stable at room temperature for three months.
Collapse
|
6
|
Adhikari A, Seo PR, Polli JE. Dissolution-Hollow Fiber Membrane (D-HFM) System to Anticipate Biopharmaceutics Risk of Tablets and Capsules. J Pharm Sci 2023; 112:751-759. [PMID: 36202250 DOI: 10.1016/j.xphs.2022.09.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Revised: 09/29/2022] [Accepted: 09/29/2022] [Indexed: 02/18/2023]
Abstract
A dissolution-hollow fiber membrane (D-HFM) system with relatively high area/volume ratio was previously characterized and showed favorably high percent drug absorption. Also, it's in vitro permeation constant (Kp.Ç.) was close to in vivo human permeation constant (kp). The objective of the current study was to predict the in vivo human absorption profile and biopharmaceutic performance of five drug products using the D-HFM system. Four immediate-release (IR) and one extended-release (ER) solid oral dosage form were subjected to the D-HFM system. Tablets and capsule dissolution were also measured using USP apparatus II. Drug solutions were also subjected to D-HFM testing. Predicted and observed absorption profiles in D-HFM system showed close agreement for each solid oral dosage form. Levy-Polli plots from D-HFM system successfully predicted the four IR products to be low biopharmaceutic risk due to permeation rate limited or mixed dissolution/permeation rate limited absorption, and successfully predicted metoprolol ER product to be high biopharmaceutic risk due to dissolution rate limited absorption. These observations showed potential of the in vitro D-HFM system to be utilized in biopharmaceutics risk assessment of in vivo tablet and capsule performance.
Collapse
Affiliation(s)
- Asmita Adhikari
- Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, 21201, USA
| | - Paul R Seo
- Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA
| | - James E Polli
- Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, 21201, USA.
| |
Collapse
|
7
|
Abou-Taleb HA, Shoman ME, Makram TS, Abdel-Aleem JA, Abdelkader H. Exploration of the Safety and Solubilization, Dissolution, Analgesic Effects of Common Basic Excipients on the NSAID Drug Ketoprofen. Pharmaceutics 2023; 15:pharmaceutics15020713. [PMID: 36840035 PMCID: PMC9964971 DOI: 10.3390/pharmaceutics15020713] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 02/16/2023] [Accepted: 02/17/2023] [Indexed: 02/23/2023] Open
Abstract
Since its introduction to the market in the 1970s, ketoprofen has been widely used due to its high efficacy in moderate pain management. However, its poor solubility and ulcer side effects have diminished its popularity. This study prepared forms of ketoprofen modified with three basic excipients: tris, L-lysine, and L-arginine, and investigated their ability to improve water solubility and reduce ulcerogenic potential. The complexation/salt formation of ketoprofen and the basic excipients was prepared using physical mixing and coprecipitation methods. The prepared mixtures were studied for solubility, docking, dissolution, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), in vivo evaluation for efficacy (the writhing test), and safety (ulcerogenic liability). Phase solubility diagrams were constructed, and a linear solubility (AL type) curve was obtained with tris. Docking studies suggested a possible salt formation with L-arginine using Hirshfeld surface analysis. The order of enhancement of solubility and dissolution rates was as follows: L-arginine > L-lysine > tris. In vivo analgesic evaluation indicated a significant enhancement of the onset of action of analgesic activities for the three basic excipients. However, safety and gastric protection indicated that both ketoprofen arginine and ketoprofen lysine salts were more favorable than ketoprofen tris.
Collapse
Affiliation(s)
- Heba A. Abou-Taleb
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Merit University (MUE), Sohag 82755, Egypt
| | - Mai E. Shoman
- Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt
| | - Tarek Saad Makram
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October 6 University, October 6 12585, Egypt
| | - Jelan A. Abdel-Aleem
- Department of Industrial Pharmacy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt
| | - Hamdy Abdelkader
- Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia
- Correspondence:
| |
Collapse
|
8
|
Hsen EB, Latrous L. Magnetic Solid-Phase Extraction Based on Magnetite-Multiwalled Carbon Nanotubes of Non-Steroidal Anti-Inflammatories from Water Followed by LC-ESI-MS/MS. J Chromatogr Sci 2023; 61:186-194. [PMID: 35091741 DOI: 10.1093/chromsci/bmac006] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 12/12/2021] [Accepted: 01/08/2022] [Indexed: 11/13/2022]
Abstract
An analytical method based on liquid chromatography-electrospray ionization-tandem mass spectrometry detection (LC-ESI-MS/MS) has been developed for the determination of pharmaceutical compounds in water samples. Five non-steroidal anti-inflammatory drugs (NSAIDs) namely Naproxen, Ketoprofen, Piroxicam, Diflunisal and Celecoxib were investigated. Magnetic solid phase extraction (MSPE) was used for sample pre concentration of water samples and magnetic carbon nanotubes (Fe3O4-MWCNTs) were considered as solid phase extraction sorbent. Important parameters influencing the extraction efficiency such as nature and volume of eluent, sample pH and adsorbent mass were optimized. The developed MSPE method involved 75 mg of Fe3O4-MWCNTs sorbent, 5 mL of water sample at pH = 4 and 5 mL of 10% ammonia in methanol in the elution step. Under the optimized extraction conditions, linearity, detection and quantification limits and reproducibility were evaluated. The proposed method was successfully applied to the analysis of NSAIDs in surface waters, and mean recoveries of all the NSAIDs were above 90% with relative standard deviations < 17%. The detection and quantification limits were comprised between 0.05-3.6 ng.mL-1 and 0.2-11.9 ng.mL-1, respectively.
Collapse
Affiliation(s)
- Ele Ben Hsen
- Département de Chimie, Université de Tunis El Manar, Faculté des Sciences de Tunis, Laboratoire de Chimie Analytique et Electrochimie Campus Universitaire Farhat Hached, Tunis 2092, Tunisia
| | - Latifa Latrous
- Département de Chimie, Université de Tunis El Manar, Faculté des Sciences de Tunis, Laboratoire de Chimie Minérale Appliquée (LR19ES02), Campus Universitaire Farhat Hached, Tunis 2092, Tunisia.,Département de Chimie, Université de Tunis El Manar, Institut Préparatoire aux Etudes d'Ingénieurs d'El Manar, B.P.244 El Manar II, Tunis 2092, Tunisia
| |
Collapse
|
9
|
Devi S, Kumar S, Verma V, Kaushik D, Verma R, Bhatia M. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations. Drug Deliv Transl Res 2022; 12:2693-2707. [PMID: 35178670 DOI: 10.1007/s13346-022-01120-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/15/2022] [Indexed: 12/15/2022]
Abstract
The objective of the current study is to evaluate the prospective of liquisolid formulation to improve the dissolution rate of ketoprofen and thereby the bioavailability. Different batches of liquisolid were prepared using polyethylene glycol 200 as a solvent, microcrystalline cellulose, and aerosil 200 as carrier and coating material, respectively. Central composite design (32) was utilized to examine the effects of independent variables (load factor and excipient ratio) on dependent variables (solubility and % in vitro drug release). Differential scanning calorimetry, Fourier transform infrared spectroscopy, X-ray diffraction, and scanning electron microscopy techniques were employed for characterization of optimized batch (LS-10) of liquisolid formulation. The half-maximal inhibitory concentration (IC50) values for in vitro anti-inflammatory activity for liquisolid formulation exhibited a higher anti-inflammatory effect than ketoprofen and physical mixture. The statistical analysis of in vivo (anti-inflammatory and analgesic) activities data demonstrated that the test (optimized formulation) treatment group resulted in quick pharmacological response in Wistar rats and Albino mice when compared with standard (pure drug) and control treatment groups. The results obtained in the present study illustrated that the liquisolid formulation could be a propitious approach to increase the bioavailability of ketoprofen and could be used in oral therapy.
Collapse
Affiliation(s)
- Sunita Devi
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, 125001, India
| | - Sunil Kumar
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, 125001, India
| | - Vikas Verma
- Department of Chemistry, Guru Jambheshwar University of Science and Technology, Hisar, 125001, India
| | - Deepak Kaushik
- Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India
| | - Ravinder Verma
- Department of Pharmacy, School of Medical and Allied Sciences (SoMAS), G. D. Goenka University, Sohna Road, Gurugram, 122103, India
| | - Meenakshi Bhatia
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, 125001, India.
| |
Collapse
|
10
|
Han M, Xu J, Lin Y. Approaches of formulation bridging in support of orally administered drug product development. Int J Pharm 2022; 629:122380. [DOI: 10.1016/j.ijpharm.2022.122380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 11/01/2022] [Accepted: 11/04/2022] [Indexed: 11/10/2022]
|
11
|
Usta DY, Incecayir T. Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media. AAPS PharmSciTech 2022; 23:201. [PMID: 35882662 DOI: 10.1208/s12249-022-02355-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Accepted: 07/06/2022] [Indexed: 11/30/2022] Open
Abstract
Quantitative evaluation of drug dissolution characteristics based on mathematical models is essential to understand and predict a particular drug release profile. In this study, model-dependent evaluation of the dissolution kinetics of reference and five test products (25-mg, immediate-release (IR) tablets) of an antihypertensive drug, carvedilol, was carried out using the DDSolver® program. The effects of pH (pH 1.2, 4.5, and 6.8) and various media with/without 0.5% (w/v) anionic, cationic, and nonionic surfactants (sodium lauryl sulfate (SLS), hexadecyltrimethylammonium bromide (CTAB), and polysorbate 80) on the dissolution kinetics of the bioequivalent IR products of carvedilol were investigated. The Weibull-1 model was fitted successfully to the dissolution data of all products at pH 1.2 and pH 4.5, as well as in the pH 6.8 medium with CTAB according to the model goodness of fit (r2 = 0.981-0.999, AIC = 14.5-42.6, MSC = 1.99-5.25). Model fitting produced good fits to Gompertz-1 for all products at pH 6.8 without a surfactant (r2 = 0.975-0.998, AIC = 28.3-55, MSC = 2.53-5.82). For pH 6.8 media containing SLS or polysorbate 80, Logistic-2 was fitted successfully to the dissolution data of all products (r2 = 0.974-0.999, AIC = 20.9-52.1, MSC = 1.90-5.69). Overall, the model-dependent analysis of in vitro dissolution data indicated in vitro equivalence of the reference and test products of carvedilol in each medium in terms of kinetic models, suggesting that it would have an important role in developing generic drug products of the BCS class II drug carvedilol.
Collapse
Affiliation(s)
- Duygu Yilmaz Usta
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Etiler, 06330, Ankara, Turkey
| | - Tuba Incecayir
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Etiler, 06330, Ankara, Turkey.
| |
Collapse
|
12
|
Selective terpene based therapeutic deep eutectic systems against colorectal cancer. Eur J Pharm Biopharm 2022; 175:13-26. [PMID: 35483600 DOI: 10.1016/j.ejpb.2022.04.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 03/21/2022] [Accepted: 04/21/2022] [Indexed: 01/20/2023]
Abstract
Cancer remains a major health problem worldwide, with colorectal cancer (CRC) being the third most incident and the second most lethal. Inflammation, on the other hand, has been highly associated with cancer development and maintenance, therefore, the reduction of the inflammatory microenvironment represents a promising therapeutic strategy. Deep eutectic systems (DES) are based on the combination of different components which together, at a certain molar ratio, present a deep decrease in their melting point compared with the individual compounds. When an active pharmaceutical ingredient is part of a DES it is designated by therapeutic deep eutectic system (THEDES). New THEDES combining terpenes with anticancer properties, such as safranal, menthol and linalool, with nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, ketoprofen and flurbiprofen were produced. To evaluate THEDES anti-CRC therapeutic potential, their physico-chemical properties, bioavailability and bioactivity, were explored. Our results show that safranal:ibuprofen (3:1), safranal:ibuprofen (4:1) and menthol:ibuprofen (3:1) present promising therapeutic activity towards CRC cells due to a selective cytotoxic action towards cancer cells. menthol:ibuprofen (3:1) anti-proliferative action seems to be related with cell membrane disruption, reduction of the inflammation through the reduction of reactive oxygen species (ROS) production, and induction of apoptosis via caspase-3. On the other hand, safranal:ibuprofen (3:1) and safafranal:ibuprofen (4:1) seem to prevent tumour expansion only through the induction of apoptosis via caspase-3. Besides, these systems present an increase in ibuprofen permeability, with menthol:ibuprofen (3:1) increasing also ibuprofen's solubility thus its overall bioavailability. Knowing that cancer is a huge problematic situation that requires alternative therapies with less side effects, improved efficacy, associated with less costs and environmentally friendly, a new opportunity emerges for DES to be part of the pharmaceutical industry.
Collapse
|
13
|
Cámara-Martinez I, Blechar JA, Ruiz-Picazo A, Garcia-Arieta A, Calandria C, Merino-Sanjuan V, Langguth P, Gonzalez-Alvarez M, Bermejo M, Al-Gousous J, Gonzalez-Alvarez I. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen. Int J Pharm 2021; 614:121415. [PMID: 34973409 DOI: 10.1016/j.ijpharm.2021.121415] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Revised: 12/15/2021] [Accepted: 12/18/2021] [Indexed: 12/30/2022]
Abstract
A bioequivalence study comparing two fixed dose combination tablets containing 200 mg ibuprofen and 30 mg pseudoephedrine hydrochloride showed bioequivalence for pseudoephedrine AUC and Cmax, but the reference product showed higher Cmax than the test product in fasted conditions. The main difference between products was the presence of tribasic calcium phosphate in the reference tablet, resulting in an increased surface pH of the dissolving ibuprofen particles under gastric and intestinal conditions and, consequently, higher solubility of ibuprofen. A mechanistic model based on mass balance and ionization equilibria was used to calculate the pH of the particle surface under different buffer conditions. The discrepancies in surface pH between test and reference tablet were pronounced in 0.1 M and 0.01 M hydrochloric acid and in diluted maleate 7 mM pH 6.5 and phosphate 5 mM pH 6.7 buffers (but negligible in compendial phosphate buffer pH 6.8. Only those dissolution tests using pre-treatment in acidic conditions could be used to build a one-step in vitro-in vivo correlation (IVIVC). This work shows the potential of these discriminatory and in vivo predictive dissolution methods to obtain IVIVCs for BCS class IIa drugs and for extending BCS biowaivers to BCS class IIa drugs.
Collapse
Affiliation(s)
- I Cámara-Martinez
- Engineering: Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Spain; Pharmacy, Pharmaceutical Technology and Parasitology Area, University of Valencia. Spain
| | - J A Blechar
- Institute of Pharmacy and Biomedical Science, Johannes Gutenberg University, Mainz, Germany
| | - A Ruiz-Picazo
- Engineering: Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Spain
| | - A Garcia-Arieta
- Area of Pharmacokinetics and Generic Medicines, Division of Pharmacology and Clinical Evaluation, Department of Human Use Medicines. Spanish Agency for Medicines and Health Care Products, Spain.
| | | | - V Merino-Sanjuan
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, USA
| | - P Langguth
- Institute of Pharmacy and Biomedical Science, Johannes Gutenberg University, Mainz, Germany
| | - M Gonzalez-Alvarez
- Engineering: Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Spain
| | - M Bermejo
- Engineering: Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Spain.
| | - J Al-Gousous
- Institute of Pharmacy and Biomedical Science, Johannes Gutenberg University, Mainz, Germany; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, USA
| | - I Gonzalez-Alvarez
- Engineering: Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, Spain
| |
Collapse
|
14
|
In Silico Analysis and Experimental Evaluation of Ester Prodrugs of Ketoprofen for Oral Delivery: With a View to Reduce Toxicity. Processes (Basel) 2021. [DOI: 10.3390/pr9122221] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
The present research aimed to synthesize ketoprofen prodrugs and to demonstrate their potentiality for oral treatment to treat chronic inflammation by reducing its hepatotoxicity and gastrointestinal irritation. Methyl 2-(3-benzoyl phenyl) propanoate, ethyl 2-(3-benzoyl phenyl) propanoate and propyl 2-(3-benzoyl phenyl) propanoate was synthesized by esterification and identified by nuclear magnetic resonance (1HNMR) and infrared (IR) spectrometric analysis. In silico SwissADME and ProTox-II analysis stated methyl derivative as ideal candidate for oral absorption, having a >30-fold LD50 value compared to ketoprofen with no hepatotoxicity. Moreover, in vivo hepatotoxicity study demonstrates that these ester prodrugs have significantly lower effects on liver toxicity compared to pure ketoprofen. Furthermore, ex vivo intestinal permeation enhancement ratio was statistically significant (* p < 0.05) compared to ketoprofen. Likewise, the prodrugs were found to exhibit not only remarkable in vitro anti-proteolytic and lysosomal membrane stabilization potentials, but also significant efficiency to alleviate pain induced by inflammation, as well as central and peripheral stimulus in mice model in vivo. These outcomes recommend that ketoprofen ester prodrugs, especially methyl derivative, can be a cost-effective candidate for prolonged treatment of chronic inflammatory diseases.
Collapse
|
15
|
Understanding the Impact of Multi-factorial Composition on Efficient Loading of the Stable Ketoprofen Nanoparticles on Orodispersible Films Using Box-Behnken Design. J Pharm Sci 2021; 111:1451-1462. [PMID: 34678275 DOI: 10.1016/j.xphs.2021.10.016] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 10/13/2021] [Accepted: 10/14/2021] [Indexed: 11/21/2022]
Abstract
The purpose of the present study was to prepare Orodispersible films (ODFs) loaded with ketoprofen nanoparticles (KT-NP). The Box-Behnken design was constructed in developing and optimizing the KTF-NP-ODFs. The effect of independent variables: Soluplus® concentration (X1, stabilizer), Tween 80 concentration (X2, surfactant), and KTF concentration (X3, drug) were studied on the dependent variables: particle size (PS, Y1), zeta potential (ZP, Y2), and the polydispersity index (PDI, Y3) of the NPs, as well as on the tensile strength (TS, Y4) and permeability coefficient (PC, Y5) of the KTF-NP-ODFs. Hydroxypropyl methylcellulose (HPMC E15) and polyethylene glycol (PEG 400) were used as the film former polymer and plasticizer, respectively, and their concentrations were kept constant for all formulations. KTF-NPs were prepared by antisolvent precipitation technology. This was followed by the addition of HPMC E15 and PEG 400 to prepare the ODFs using the solvent-casting method. The PS, PDI, and ZP for all the formulations were found in the range of 94 nm to 350 nm, 0.09 to 0.438, and -21.83 mV to -8.03 mV, respectively. The TS and PC of the prepared KTF-NP-ODFs were found between 1.21 MPa to 3.93 MPa and 3.12 × 10-4 cm/h to 34.23 × 10-4 cm/h, respectively. The amorphous nature of the KTF-NP in the ODFs was confirmed by the absence of characteristic crystalline peaks and endothermic events of KTF in X-ray diffraction (XRD) and modulated differential scanning calorimetry (mDSC), respectively. The optimized formulation showed ̴ 4 times higher permeability as compared to the pure KTF. In addition, the dissolution of pure KTF and the optimized KTF-NP-ODF in pH 1.2 at the end of 60 min was found to be ̴ 30% and ̴ 95%, respectively. Conclusively, KTF-NP-ODFs can be a promising drug delivery system to counter the issues related to dysphagia and bypass the common side effects, such as the gastric irritation associated with NSAIDs like KTF.
Collapse
|
16
|
Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs. Pharmaceutics 2021; 13:pharmaceutics13101620. [PMID: 34683913 PMCID: PMC8540160 DOI: 10.3390/pharmaceutics13101620] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 09/15/2021] [Accepted: 09/28/2021] [Indexed: 11/16/2022] Open
Abstract
Most nonsteroidal anti-inflammatory drugs (NSAIDs) present poor aqueous solubility, impairing their efficiency in physiological media. In this context, Low Transition Temperature Mixtures (LTTMs) are a promising platform to overcome drugs' poor solubility, forming therapeutic liquid formulations. In this work, the LTTMs of citric acid:L-arginine:water (C:A:W) and glycerol:sorbitol (G:S) were studied in terms of their features and assessed in terms of their ability to increase the solubility of six NSAIDs in physiological media. The physicochemical properties of LTTMs were characterized by state-of-art techniques commonly used for these systems. The cytotoxicity of G:S was also evaluated in L929 mouse fibroblasts and the viscosity, polarity, and pH properties of the studied mixtures were related to the solubility of NSAIDs. The pH and polarity were the parameters that most influenced the drugs' solubility. Ibuprofen, naproxen, ketoprofen, indomethacin, and flurbiprofen did not present any solubility improvement in the formulations tested. However, concentrated mixtures of C:A:W or G:S in the physiologic-mimicked media (PBS) rendered a celecoxib solubility 4 and 5 times higher than PBS, respectively. These therapeutic liquid formulations of celecoxib in C:A:W or G:S can be a promising tool to increase celecoxib's therapeutic efficiency in local applications.
Collapse
|
17
|
An Assessment of Occasional Bio-Inequivalence for BCS1 and BCS3 Drugs: What are the Underlying Reasons? J Pharm Sci 2021; 111:124-134. [PMID: 34363838 DOI: 10.1016/j.xphs.2021.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 08/02/2021] [Accepted: 08/02/2021] [Indexed: 11/20/2022]
Abstract
Despite having adequate solubility properties, bioequivalence (BE) studies performed on immediate release formulations containing BCS1/3 drugs occasionally fail. By systematically evaluating a set of 17 soluble drugs where unexpected BE failures have been reported and comparing to a set of 29 drugs where no such reports have been documented, a broad assessment of the risk factors leading to BE failure was performed. BE failures for BCS1/3 drugs were predominantly related to changes in Cmax rather than AUC. Cmax changes were typically modest, with minimal clinical significance for most drugs. Overall, drugs with a sharp plasma peak were identified as a key factor in BE failure risk. A new pharmacokinetic term (t½Cmax) is proposed to identify drugs at higher risk due to their peak plasma profile shape. In addition, the analysis revealed that weak acids, and drugs with particularly high gastric solubility are potentially more vulnerable to BE failure, particularly when these features are combined with a sharp Cmax peak. BCS3 drugs, which are often characterised as being more vulnerable to BE failure due to their potential for permeation and transit to be altered, particularly by excipient change, were not in general at greater risk of BE failures. These findings will help to inform how biowaivers may be optimally applied in the future.
Collapse
|
18
|
Polyvinyl Alcohol-Based 3D Printed Tablets: Novel Insight into the Influence of Polymer Particle Size on Filament Preparation and Drug Release Performance. Pharmaceuticals (Basel) 2021; 14:ph14050418. [PMID: 34062744 PMCID: PMC8147252 DOI: 10.3390/ph14050418] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 04/23/2021] [Accepted: 04/26/2021] [Indexed: 12/31/2022] Open
Abstract
Three-dimensional printing (3DP) by fused deposition modeling (FDM) has gained momentum as a promising pharmaceutical manufacturing method due to encouraging forward-looking perspectives in personalized medicine preparation. The current challenges the technology has for applicability in the fabrication of solid dosage forms include the limited range of suitable pharmaceutical grade thermoplastic materials. Hence, it is important to investigate the implications of variable properties of the polymeric carrier on the preparation steps and the final output, as versatile products could be obtained by using the same material. In this study, we highlighted the influence of polyvinyl alcohol (PVA) particle size on the residence time of the mixtures in the extruder during the drug-loaded filament preparation step and the consequent impact on drug release from the 3D printed dosage form. We enhanced filament printability by exploiting the plasticizing potential of the active pharmaceutical ingredient (API) and we explored a channeled tablet model as a design strategy for dissolution facilitating purposes. Our findings disclosed a new perspective regarding material considerations for the preparation of PVA-based solid dosage forms by coupling hot melt extrusion (HME) and FDM-3DP.
Collapse
|
19
|
Das SK, Chakraborty S, Bose A, Rajabalaya R, Khanam J. Effects of the preparation technique on the physicochemical characteristics and dissolution improvement of ketoprofen-SBE7-β-CD binary inclusion complexes. Colloids Surf A Physicochem Eng Asp 2021. [DOI: 10.1016/j.colsurfa.2020.125775] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
20
|
Martins MAR, Silva LP, Jorge PS, Abranches DO, Pinho SP, Coutinho JAP. The role of ionic vs. non-ionic excipients in APIs-based eutectic systems. Eur J Pharm Sci 2021; 156:105583. [PMID: 33045368 DOI: 10.1016/j.ejps.2020.105583] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 09/03/2020] [Accepted: 10/01/2020] [Indexed: 11/17/2022]
Abstract
Aiming to contribute to drug pre-formulation, new eutectic mixtures were developed. Thymol, coumarin, or quaternary ammonium chlorides as excipients, were combined with the active pharmaceutical ingredients (APIs) acetylsalicylic acid, acetaminophen, ibuprofen, ketoprofen, or lidocaine. Their solid-liquid equilibrium (SLE) binary phase diagrams were measured to study eventual phase separation between the compounds, preventing manufacturing problems, and to study the molecular interactions between the APIs and ionic or non-ionic excipients. The Conductor-like Screening Model for Real Solvents (COSMO-RS) capability to predict the SLE of mixtures containing non-ionic excipients was further evaluated. COSMO-RS gives a good quantitative description of the experimental SLE being a tool with great potential in the screening of eutectic systems containing APIs and non-ionic excipients. While thymol presents strong interactions with the APIs, and consequently negative deviations to thermodynamic ideality, systems containing coumarin follow a quasi-ideal behavior. Regarding the ionic excipients, both choline chloride and the tetraalkylammonium chlorides are unable to establish relevant interactions with the APIs, and no significant negative deviations to ideality are observed. The liquefaction of the APIs here studied is favored by using non-ionic excipients, such as thymol, due to the strong interactions it can establish with the APIs.
Collapse
Affiliation(s)
- Mónia A R Martins
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
| | - Liliana P Silva
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
| | - Patrícia S Jorge
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
| | - Dinis O Abranches
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
| | - Simão P Pinho
- Mountain Research Center - CIMO, Polytechnic Institute of Bragança, 5301-855 Bragança, Portugal
| | - João A P Coutinho
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
| |
Collapse
|
21
|
Elezović A, Marić A, Biščević A, Hadžiabdić J, Škrbo S, Špirtović-Halilović S, Rahić O, Vranić E, Elezović A. In vitro pH dependent passive transport of ketoprofen and metformin. ADMET AND DMPK 2020; 9:57-68. [PMID: 35299877 PMCID: PMC8923306 DOI: 10.5599/admet.916] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 12/02/2020] [Indexed: 11/18/2022] Open
Abstract
The kinetics of passive transport of ketoprofen and metformin, as model substances for high and low permeability, respectively, across the artificial membrane under the influence of the pH of donor solution was investigated. There was an upward trend in the apparent permeation coefficient (P app) of ketoprofen with the decrease in pH to a value close to pKa. At the pH value below pKa the permeation coefficient had lower value, due to the higher retention of ketoprofen in the artificial membrane. Metformin is a low permeable compound, and the highest permeation values were recorded at pH 7.4. Two dissociation constants determine that metformin at physiological pH exists as a hydrophilic cationic molecule, i.e. predominantly in ionized form. At pH values below 2.8, metformin mainly exists in diprotonated form, and it was, thus, very poorly permeable. The highest retention, i.e. affinity of both ketoprofen and metformin to the membrane, was at the lowest pH values, which is explained by different mechanisms. At higher pH values of donor compartment the substances showed significantly less affinity to the membrane. The obtained values of apparent permeation coefficients at studied pH values showed good correlation with the obtained experimental values by other in vitro methods.
Collapse
Affiliation(s)
- Alisa Elezović
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Amina Marić
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Amila Biščević
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Jasmina Hadžiabdić
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Selma Škrbo
- Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo
| | - Selma Špirtović-Halilović
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Ognjenka Rahić
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Edina Vranić
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Sarajevo, Zmaja od Bosne 8, 71000 Sarajevo, Bosnia and Herzegovina
| | - Amar Elezović
- Control Laboratory of the Agency for Medicinal Products and Medical Devices, Titova 9, 71000 Sarajevo
| |
Collapse
|
22
|
Pagano C, Latterini L, Di Michele A, Luzi F, Puglia D, Ricci M, Antonio Viseras Iborra C, Perioli L. Polymeric Bioadhesive Patch Based on Ketoprofen-Hydrotalcite Hybrid for Local Treatments. Pharmaceutics 2020; 12:pharmaceutics12080733. [PMID: 32759858 PMCID: PMC7464538 DOI: 10.3390/pharmaceutics12080733] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Revised: 07/28/2020] [Accepted: 08/02/2020] [Indexed: 11/23/2022] Open
Abstract
Ketoprofen (KET) represents one of the most common drugs used in the topical treatment of pain and inflammations. However, its potential is rather limited due to the very low solubility and photochemical instability. The local administration of KET by conventional products, such as gels, emulgels, creams, and foams, does not guarantee an efficacious and safe treatment because of its low absorption (due to low solubility) and its sensitivity to UV rays. The photodegradation of KET makes many photoproducts responsible for different adverse effects. In the present work, KET was intercalated into the lamellar anionic clay ZnAl-hydrotalcite (ZnAl-HTlc), obtaining the hybrid ZnAl-KET with improved stability to UV rays and water solubility in comparison to the crystalline form (not intercalated KET). The hybrid was then formulated in autoadhesive patches for local pain treatment. The patches were prepared by casting method starting from a hydrogel based on the biocompatible and bioadhesive polymer NaCMC (Sodium carboxymethycellulose) and glycerol as a plasticizing agent. The introduction of ZnAl-KET in the patch composition demonstrated the improvement in the mechanical properties of the formulation. Moreover, a sustained and complete KET release was obtained within 8 h. This allowed reducing the frequency of anti-inflammatory administration, compared to the conventional formulations.
Collapse
Affiliation(s)
- Cinzia Pagano
- Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia Italy; (C.P.); (M.R.)
| | - Loredana Latterini
- Department of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy;
| | | | - Francesca Luzi
- Civil and Environmental Engineering Department, University of Perugia, UdR INSTM, 05100 Terni, Italy; (F.L.); (D.P.)
| | - Debora Puglia
- Civil and Environmental Engineering Department, University of Perugia, UdR INSTM, 05100 Terni, Italy; (F.L.); (D.P.)
| | - Maurizio Ricci
- Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia Italy; (C.P.); (M.R.)
| | - César Antonio Viseras Iborra
- Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Campus of Cartuja, 18071 Granada, Spain;
| | - Luana Perioli
- Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia Italy; (C.P.); (M.R.)
- Correspondence: ; Tel.: +39-075-585-5133 or +39-075-585-5123
| |
Collapse
|
23
|
Taha NF, Emam MF, Emara LH. A novel combination of Soluplus®/Poloxamer for Meloxicam solid dispersions via hot melt extrusion for rapid onset of action. Part 2: comparative bioavailability and IVIVC. Drug Dev Ind Pharm 2020; 46:1362-1372. [DOI: 10.1080/03639045.2020.1791164] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Nesrin F. Taha
- Medicinal and Pharmaceutical Chemistry Department, Division of Pharmaceutical and Drug Industries Research, Industrial Pharmacy Laboratory, National Research Centre, Giza, Egypt
| | - Maha F. Emam
- Medicinal and Pharmaceutical Chemistry Department, Division of Pharmaceutical and Drug Industries Research, Industrial Pharmacy Laboratory, National Research Centre, Giza, Egypt
| | - Laila H. Emara
- Medicinal and Pharmaceutical Chemistry Department, Division of Pharmaceutical and Drug Industries Research, Industrial Pharmacy Laboratory, National Research Centre, Giza, Egypt
| |
Collapse
|
24
|
Oliveira LJ, Veiga A, Stofella NCF, Cunha AC, da Graça T. Toledo M, Andreazza IF, Murakami FS. Development and Evaluation of Orodispersible Tablets Containing Ketoprofen. Curr Drug Deliv 2020; 17:348-360. [DOI: 10.2174/1567201817666200317122807] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2019] [Revised: 02/06/2020] [Accepted: 02/20/2020] [Indexed: 12/30/2022]
Abstract
Background:
Orodispersible Tablets (ODTs) are an option to facilitate the intake of pharmaceutical
solid dosage forms, which dissolve in the mouth within 30 seconds releasing the drug immediately
with no need for water intake or chewing.
Objective:
The main goal of our study is the technological development of lactose-free orodispersible
tablets that contain ketoprofen.
Methods:
We assessed different variables during the pharmaceutical development of ODTs: compression
techniques conducted after a wet granulation process, aiming to optimize the flow properties of the
formulation, and a suspension freeze-drying molded in blisters. We developed three formulations for
each method, each containing one of the superdisintegrants: croscarmellose, crospovidone, or starch
glycolate.
Result:
During the production of ODTs, we performed quality control of the granulation process, since
the production of pellets contributed to the enhancement of the disintegration time and content homogeneity.
Quality control tests for ODTs produced by freeze-drying were also satisfactory, despite significant
changes in the final physical aspect of these products when compared to that of ODTs produced
by compression. In addition, the disintegration times of ODTs produced by freeze-drying were substantially
higher. Furthermore, these tablets displayed greater friability and pose a challenge to the control
of a standard individual weight.
Conclusion:
Among the superdisintegrants, croscarmellose contributed most significantly to reduce the
disintegration time and to dissolve KTP effectively in 20 minutes.
Collapse
Affiliation(s)
- Laiane J. Oliveira
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| | - Andressa Veiga
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| | - Nayana C. F. Stofella
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| | - Aline Carolina Cunha
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| | - Maria da Graça T. Toledo
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| | - Itamar F. Andreazza
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| | - Fabio S. Murakami
- Programa de Pos-Graduacao em Ciencias Farmaceuticas, Universidade Federal do Parana, Curitiba, Brazil
| |
Collapse
|
25
|
Tsume Y, Igawa N, Drelich AJ, Ruan H, Amidon GE, Amidon GL. The in vivo predictive dissolution for immediate release dosage of donepezil and danazol, BCS class IIc drugs, with the GIS and the USP II with biphasic dissolution apparatus. J Drug Deliv Sci Technol 2020. [DOI: 10.1016/j.jddst.2019.01.035] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
26
|
Buzharevski A, Paskas S, Laube M, Lönnecke P, Neumann W, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E. Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines. ACS OMEGA 2019; 4:8824-8833. [PMID: 31459970 PMCID: PMC6648485 DOI: 10.1021/acsomega.9b00412] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Accepted: 04/17/2019] [Indexed: 05/04/2023]
Abstract
Ketoprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID) that also exhibits cytotoxic activity against various cancers. This makes ketoprofen an attractive structural lead for the development of new NSAIDs and cytotoxic agents. Recently, the incorporation of carboranes as phenyl mimetics in structures of established drugs has emerged as an attractive strategy in drug design. Herein, we report the synthesis and evaluation of four novel carborane-containing derivatives of ketoprofen, two of which are prodrug esters with an nitric oxide-releasing moiety. One of these prodrug esters exhibited high cytostatic activity against melanoma and colon cancer cell lines. The most pronounced activity was found in cell lines that are sensitive to oxidative stress, which was apparently induced by the ketoprofen analogue.
Collapse
Affiliation(s)
- Antonio Buzharevski
- Institut
für Anorganische Chemie, Universität
Leipzig, Johannisallee 29, D-04103 Leipzig, Germany
| | - Svetlana Paskas
- Department
of Immunology, Institute for Biological Research “Sinisa Stankovic”, Belgrade University, Belgrade 11060, Serbia
| | - Markus Laube
- Institut
für Radiopharmazeutische Krebsforschung, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstrasse 400, D-01328 Dresden, Germany
| | - Peter Lönnecke
- Institut
für Anorganische Chemie, Universität
Leipzig, Johannisallee 29, D-04103 Leipzig, Germany
| | - Wilma Neumann
- Institut
für Anorganische Chemie, Universität
Leipzig, Johannisallee 29, D-04103 Leipzig, Germany
| | - Blagoje Murganic
- Department
of Immunology, Institute for Biological Research “Sinisa Stankovic”, Belgrade University, Belgrade 11060, Serbia
| | - Sanja Mijatovic
- Department
of Immunology, Institute for Biological Research “Sinisa Stankovic”, Belgrade University, Belgrade 11060, Serbia
| | - Danijela Maksimovic-Ivanic
- Department
of Immunology, Institute for Biological Research “Sinisa Stankovic”, Belgrade University, Belgrade 11060, Serbia
| | - Jens Pietzsch
- Institut
für Radiopharmazeutische Krebsforschung, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstrasse 400, D-01328 Dresden, Germany
- Faculty
of Chemistry and Food Chemistry, Technische
Universität Dresden, Mommsenstrasse 4, D-01062 Dresden, Germany
| | - Evamarie Hey-Hawkins
- Institut
für Anorganische Chemie, Universität
Leipzig, Johannisallee 29, D-04103 Leipzig, Germany
- E-mail: . Fax: (+49)341-9739319
| |
Collapse
|
27
|
Deák Á, Sebők D, Csapó E, Bérczi A, Dékány I, Zimányi L, Janovák L. Evaluation of pH- responsive poly(styrene-co-maleic acid) copolymer nanoparticles for the encapsulation and pH- dependent release of ketoprofen and tocopherol model drugs. Eur Polym J 2019. [DOI: 10.1016/j.eurpolymj.2019.03.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
28
|
Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility. Pharmaceutics 2019; 11:pharmaceutics11020068. [PMID: 30736357 PMCID: PMC6409705 DOI: 10.3390/pharmaceutics11020068] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2019] [Revised: 01/31/2019] [Accepted: 02/01/2019] [Indexed: 12/18/2022] Open
Abstract
The formulation of arylpropionic acid derivatives (profens), which are poorly soluble Biopharmaceutical Classification System (BCS) Type II drugs, has a strong impact on their therapeutic action. This article shows that heat-treated powder mixtures of free acid profens with high surface area Cladophora cellulose induces drug amorphization and results in enhanced solubility and bioavailability. Similar mixtures produced using conventional low surface area cellulose, i.e., microcrystalline cellulose, does not produce the same effect. The concept is thoroughly described and links the solid-state characterization data, such as differential scanning calorimetry, X-ray powder diffraction, and Fourier-transform infra-red spectroscopy, with in vitro dissolution in biorelevant media and in vivo pharmacokinetic analysis in rats. The concept is demonstrated for several substances from the profens group, including ibuprofen (main model drug), ketoprofen, flurbiprofen, and naproxen. The presented approach opens new ways to produce solid dosage forms of profen drugs in their free acidic form as alternatives to existing analogues, e.g., drug-salt conjugates or soft gel liquid capsules.
Collapse
|
29
|
Wicaksono Y, Setyawan D, Siswandono S. Multicomponent Crystallization of Ketoprofen-nicotinamide for Improving the Solubility and Dissolution Rate. CHEMISTRY JOURNAL OF MOLDOVA 2018. [DOI: 10.19261/cjm.2018.493] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
|
30
|
Murawsky M, Kelm GR, Kozak D, Qin B, Zou Y, Li SK. Influencing factors on gelatin matrix for chlorhexidine delivery. Drug Dev Ind Pharm 2018; 45:314-322. [PMID: 30372644 DOI: 10.1080/03639045.2018.1539744] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
OBJECTIVE The objective was to evaluate the influencing factors in the fabrication of gelatin matrix (gelatin chips) for drug delivery. The attributes affecting drug release characteristics of the gelatin products were examined. SIGNIFICANCE Understanding the attributes that affect drug release from gelatin matrix could provide the knowledge base for the development, manufacturing, and performance evaluation of gelatin-based drug products for sustained drug delivery. METHODS Chlorhexidine (CHX) was the model drug in the gelatin-product testing. The gelatin products were fabricated by two methods: a single-pot mixing of all the components and a two-step gelatin crosslinking followed by drug loading. Different gelatin types (Type A porcine and Type B bovine), glutaraldehyde (GTA) crosslinking conditions, glycerin concentration, and CHX concentration in drug loading and loading time were used to fabricate the products. The cumulative amounts of CHX release from the gelatin products were determined using in vitro release testing (IVRT). RESULTS The attributes affecting CHX release from the gelatin products were gelatin type, GTA crosslinking, and CHX loading concentration. The fabrication methods (two-step method of gelatin crosslinking and drug loading by equilibration vs. direct mixing of the components) also affected CHX release. Other attributes such as glycerin and CHX loading time did not show significant effects on drug release under the conditions studied. In addition, the results in the two IVRT methods employed in this study were comparable. CONCLUSION Gelatin products of qualitative (Q1) and quantitative (Q2) differences could lead to different drug release behaviors. Drug release was also affected by the ingredient mixing steps during gelatin chip fabrication.
Collapse
Affiliation(s)
- Michael Murawsky
- a Division of Pharmaceutical Sciences , James L Winkle College of Pharmacy, University of Cincinnati , Cincinnati , OH , USA
| | - Gary R Kelm
- a Division of Pharmaceutical Sciences , James L Winkle College of Pharmacy, University of Cincinnati , Cincinnati , OH , USA
| | - Darby Kozak
- b Office of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration , Silver Spring , MD , USA
| | - Bin Qin
- b Office of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration , Silver Spring , MD , USA
| | - Yuan Zou
- b Office of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration , Silver Spring , MD , USA
| | - S Kevin Li
- a Division of Pharmaceutical Sciences , James L Winkle College of Pharmacy, University of Cincinnati , Cincinnati , OH , USA
| |
Collapse
|
31
|
Freitas EDD, Rosa PCP, Silva MGCD, Vieira MGA. Development of sericin/alginate beads of ketoprofen using experimental design: Formulation and in vitro dissolution evaluation. POWDER TECHNOL 2018. [DOI: 10.1016/j.powtec.2018.05.016] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
32
|
Gaitán-Tolosa IM, Montiel-Campos R, Flores-Estrada J, Domínguez-García MV, Flores-Merino MV. Characterization of ketoprofen-loaded PEG-CH semi-IPN system for wound dressing application. J Appl Polym Sci 2018. [DOI: 10.1002/app.46644] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Ibeth M. Gaitán-Tolosa
- Laboratorio de Biología Molecular y Celular, Centro de Investigación en Ciencias Médicas; Universidad Autónoma del Estado de México; Estado de México 50130 México
- Facultad de Enfermería y Obstetricia; Universidad Autónoma del Estado de México; Estado de México 50180 México
| | - Raúl Montiel-Campos
- Departamento de Física, Área de Polímeros; Universidad Autónoma Metropolitana Iztapalapa; Ciudad de México 09340 México
| | - Jaime Flores-Estrada
- Facultad de Química; Universidad Autónoma del Estado de México; Estado de México 50180 México
| | - Ma. Victoria Domínguez-García
- Laboratorio de Biología Molecular y Celular, Centro de Investigación en Ciencias Médicas; Universidad Autónoma del Estado de México; Estado de México 50130 México
| | - Miriam V. Flores-Merino
- Laboratorio de Biología Molecular y Celular, Centro de Investigación en Ciencias Médicas; Universidad Autónoma del Estado de México; Estado de México 50130 México
| |
Collapse
|
33
|
Dahlgren D, Roos C, Johansson P, Tannergren C, Lundqvist A, Langguth P, Sjöblom M, Sjögren E, Lennernäs H. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs. Int J Pharm 2018; 547:158-168. [PMID: 29758344 DOI: 10.1016/j.ijpharm.2018.05.029] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 05/04/2018] [Accepted: 05/10/2018] [Indexed: 01/16/2023]
Abstract
Pharmaceutical excipients that may affect gastrointestinal (GI) drug absorption are called critical pharmaceutical excipients, or absorption-modifying excipients (AMEs) if they act by altering the integrity of the intestinal epithelial cell membrane. Some of these excipients increase intestinal permeability, and subsequently the absorption and bioavailability of the drug. This could have implications for both the assessment of bioequivalence and the efficacy of the absorption-enhancing drug delivery system. The absorption-enhancing effects of AMEs with different mechanisms (chitosan, sodium caprate, sodium dodecyl sulfate (SDS)) have previously been evaluated in the rat single-pass intestinal perfusion (SPIP) model. However, it remains unclear whether these SPIP data are predictive in a more in vivo like model. The same excipients were in this study evaluated in rat and dog intraintestinal bolus models. SDS and chitosan did exert an absorption-enhancing effect in both bolus models, but the effect was substantially lower than those observed in the rat SPIP model. This illustrates the complexity of the AME effects, and indicates that additional GI physiological factors need to be considered in their evaluation. We therefore recommend that AME evaluations obtained in transit-independent, preclinical permeability models (e.g. Ussing, SPIP) should be verified in animal models better able to predict in vivo relevant GI effects, at multiple excipient concentrations.
Collapse
Affiliation(s)
- D Dahlgren
- Department of Pharmacy, Uppsala University, Uppsala, Sweden
| | - C Roos
- Department of Pharmacy, Uppsala University, Uppsala, Sweden
| | | | | | | | - P Langguth
- School of Pharmacy, Johannes Gutenberg-University, Mainz, Germany
| | - M Sjöblom
- Department of Neuroscience, Division of Physiology, Uppsala University, Uppsala, Sweden
| | - E Sjögren
- Department of Pharmacy, Uppsala University, Uppsala, Sweden
| | - H Lennernäs
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
| |
Collapse
|
34
|
Guarino V, Caputo T, Calcagnile P, Altobelli R, Demitri C, Ambrosio L. Core/shell cellulose-based microspheres for oral administration of Ketoprofen Lysinate. J Biomed Mater Res B Appl Biomater 2018; 106:2636-2644. [DOI: 10.1002/jbm.b.34080] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Revised: 01/03/2018] [Accepted: 01/08/2018] [Indexed: 12/14/2022]
Affiliation(s)
- Vincenzo Guarino
- Department of Chemical Sciences & Materials Technology, Institute for Polymers, Composites and Biomaterials; National Research Council of Italy; 80125 Naples Italy
| | - Tania Caputo
- Department of Chemical Sciences & Materials Technology, Institute for Polymers, Composites and Biomaterials; National Research Council of Italy; 80125 Naples Italy
| | | | - Rosaria Altobelli
- Department of Chemical Sciences & Materials Technology, Institute for Polymers, Composites and Biomaterials; National Research Council of Italy; 80125 Naples Italy
| | - Christian Demitri
- Department of Engineering for Innovation; University of Salento; Lecce Italy
| | - Luigi Ambrosio
- Department of Chemical Sciences & Materials Technology, Institute for Polymers, Composites and Biomaterials; National Research Council of Italy; 80125 Naples Italy
| |
Collapse
|
35
|
The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene. J Pharm Sci 2018; 107:307-316. [DOI: 10.1016/j.xphs.2017.09.002] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2017] [Revised: 09/01/2017] [Accepted: 09/07/2017] [Indexed: 12/19/2022]
|
36
|
Jin C, Zhao C, Shen D, Dong W, Liu H, He Z. Evaluating bioequivalence of meloxicam tablets: is in-vitro dissolution test overdiscriminating? ACTA ACUST UNITED AC 2017; 70:250-258. [PMID: 29193077 DOI: 10.1111/jphp.12859] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Accepted: 10/24/2017] [Indexed: 11/30/2022]
Abstract
OBJECTIVES The aim of the study was to assess the impact of the differences in dissolution profiles of meloxicam tablets on the in-vivo bioavailability parameters after oral administration. METHODS Compare in-vitro dissolution testing in the recommended media to evaluate in-vivo bioequivalence outcomes for the Biopharmaceutics Classification System Class II weak acidic drugs. Nine Beagle dogs received a single oral administration of each formulation (7.5 mg) in a three-way crossover design. KEY FINDINGS The dissolution of meloxicam from both test products showed marked differences with that from the reference tablet in pH 1.0, 4.5 and 6.8 media at 50 or 75 rpm. Both formulations exhibiting slow or fast dissolution were then compared with the reference product for in-vivo bioequivalence study. Both products were bioequivalent with the reference tablet in either extent or rate of oral absorption. It indicated that the dissolution profiles which discriminated between the formulations in vitro did not accurately predict the in-vivo bioequivalence outcomes. CONCLUSIONS Comparative dissolution profiles using similarity factor (f2 ) in the recommended media should be relaxed to fulfil the requirements for the development, scale-up and postapproval changes to immediate release oral solid dosage forms of meloxicam.
Collapse
Affiliation(s)
- Chan Jin
- School of Wuya, Shenyang Pharmaceutical University, Shenyang, China
| | - Chenyao Zhao
- School of Wuya, Shenyang Pharmaceutical University, Shenyang, China
| | - Dachao Shen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Wenxiang Dong
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Hongzhuo Liu
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | - Zhonggui He
- School of Wuya, Shenyang Pharmaceutical University, Shenyang, China
| |
Collapse
|
37
|
Wais U, Jackson AW, He T, Zhang H. Formation of hydrophobic drug nanoparticles via ambient solvent evaporation facilitated by branched diblock copolymers. Int J Pharm 2017; 533:245-253. [DOI: 10.1016/j.ijpharm.2017.09.067] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2017] [Revised: 09/07/2017] [Accepted: 09/26/2017] [Indexed: 01/06/2023]
|
38
|
Comparison of segmental-dependent permeability in human and in situ perfusion model in rat. Eur J Pharm Sci 2017; 107:191-196. [DOI: 10.1016/j.ejps.2017.06.033] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2017] [Revised: 06/26/2017] [Accepted: 06/26/2017] [Indexed: 11/18/2022]
|
39
|
Azevedo AM, Costa SP, Dias AF, Marques AH, Pinto PC, Bica K, Ressmann AK, Passos ML, Araújo AR, Reis S, Saraiva MLM. Anti-inflammatory choline based ionic liquids: Insights into their lipophilicity, solubility and toxicity parameters. J Mol Liq 2017. [DOI: 10.1016/j.molliq.2017.02.027] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
40
|
Porażka J, Karbownik A, Murawa D, Spychała A, Firlej M, Grabowski T, Murawa P, Grześkowiak E, Szałek E. The pharmacokinetics of oral ketoprofen in patients after gastric resection. Pharmacol Rep 2016; 69:296-299. [PMID: 28178590 DOI: 10.1016/j.pharep.2016.11.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Accepted: 11/28/2016] [Indexed: 12/21/2022]
Abstract
BACKGROUND Total and partial gastric resection may affect the pharmacokinetics of drugs, especially orally administered a few days after surgery. Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) broadly used to treat postoperative pain, including patients after gastric resection. The aim of the research was to analyse the pharmacokinetics (PK) of orally administered ketoprofen in patients after gastrectomy. METHODS The research was carried out on two groups of patients after total (TG; Roux-Y procedure) and partial (PG; Billroth II procedure) gastrectomy. The patients in group TG (n=15; mean [SD] age 61.86 [14.15] years; and BMI 24.20 [3.73] kg/m2) and group PG (n=5; mean [SD] age 62.40 [16.80] years; and BMI 23.98 [3.45] kg/m2) received ketoprofen in a single oral dose of 100mg. The measurement of ketoprofen plasma concentrations was made by means of the HPLC (high performance liquid chromatography) method. RESULTS The PK parameters in group TG and PG were as follows: maximum plasma concentration (Cmax), 3.42 [0.99] and 4.66 [0.81] mg/l (p=0.0220); area under the plasma concentration-time curve from zero to infinity (AUC0-∞), 9.12 [2.78] and 9.17 [2.87] mg×h/ml (p=0.9734); area under the first moment curve from zero to the time of infinity (AUMC0-∞), 25.95 [8.52] and 26.53 [11.43] mg×h2/l (p=0.9056); time to reach maximum concentration (tmax), 0.47 [0.25] and 0.55 [0.27] h (p=0.5327), respectively. CONCLUSIONS Lower concentrations of ketoprofen in patients after gastrectomy suggest that it might be necessary to apply higher dose of the analgesic.
Collapse
Affiliation(s)
- Joanna Porażka
- Department of Clinical Pharmacy and Biopharmacy, Karol Marcinkowski University of Medical Sciences, Poznań, Poland.
| | - Agnieszka Karbownik
- Department of Clinical Pharmacy and Biopharmacy, Karol Marcinkowski University of Medical Sciences, Poznań, Poland
| | - Dawid Murawa
- 1st Department of Surgical Oncology and General Surgery, Wielkopolska Cancer Centre, Poznań, Poland; College of Health, Beauty Care and Education, Faculty of Cosmetology and Educational Sciences, Poznań, Poland
| | - Arkadiusz Spychała
- 1st Department of Surgical Oncology and General Surgery, Wielkopolska Cancer Centre, Poznań, Poland
| | - Magdalena Firlej
- Department of Clinical Pharmacy and Biopharmacy, Karol Marcinkowski University of Medical Sciences, Poznań, Poland
| | | | - Paweł Murawa
- 1st Department of Surgical Oncology and General Surgery, Wielkopolska Cancer Centre, Poznań, Poland
| | - Edmund Grześkowiak
- Department of Clinical Pharmacy and Biopharmacy, Karol Marcinkowski University of Medical Sciences, Poznań, Poland
| | - Edyta Szałek
- Department of Clinical Pharmacy and Biopharmacy, Karol Marcinkowski University of Medical Sciences, Poznań, Poland
| |
Collapse
|
41
|
Dahlgren D, Roos C, Lundqvist A, Abrahamsson B, Tannergren C, Hellström PM, Sjögren E, Lennernäs H. Regional Intestinal Permeability of Three Model Drugs in Human. Mol Pharm 2016; 13:3013-21. [DOI: 10.1021/acs.molpharmaceut.6b00514] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- David Dahlgren
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| | - Carl Roos
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| | | | | | | | - Per M. Hellström
- Department
of Medical Sciences, Uppsala University, Uppsala SE-751 05, Sweden
| | - Erik Sjögren
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| | - Hans Lennernäs
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| |
Collapse
|
42
|
Dahlgren D, Roos C, Johansson P, Lundqvist A, Tannergren C, Abrahamsson B, Sjögren E, Lennernäs H. Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms. Mol Pharm 2016; 13:3022-33. [DOI: 10.1021/acs.molpharmaceut.6b00515] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- David Dahlgren
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| | - Carl Roos
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| | | | | | | | | | - Erik Sjögren
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| | - Hans Lennernäs
- Department
of Pharmacy, Uppsala University, Uppsala SE-751 23, Sweden
| |
Collapse
|
43
|
Abd-Elrahman AA, El Nabarawi MA, Hassan DH, Taha AA. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Drug Deliv 2016; 23:3387-3398. [PMID: 27167529 DOI: 10.1080/10717544.2016.1186251] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
SBA-15 is used to enhance the bioavailability of poorly soluble ketoprofen (KP) through stabilization of its amorphous state. Additionally, the current work provides a complete in vitro and in vivo study on preformulated KP-SBA-15 sample and formulated KP-SBA-15 in hard gelatin capsule. Loading of KP was done by a novel method called immersion-rotavapor method. KP was quantified by extraction and thermal gravimetric analysis (TGA). Characterization of the loaded SBA-15 sample was done by high resolution transmission electron microscopy (HRTEM), small angle X-ray diffraction (SAXRD), nitrogen adsorption/desorption isotherms, differential scanning calorimetry (DSC), Fourier transform infrared (FT-IR) spectroscopy and dissolution profiles. The loaded sample was formulated in hard gelatin capsule. The anti-inflammatory and analgesic studies were carried out on 24 adult male albino rats. TGA and extraction results showed 54.4 wt% of drug incorporated. Characterization of KP-SBA-15 sample confirmed the successful encapsulation of KP into the carrier pores in a molecular amorphous state. Additionally, loading of KP did not affect the mesoporous internal structure. During the first 5 min, the dissolution study showed very high release rates; nearly 50% of KP was released. These results were reflected on the in vivo study resulting in 82% inhibition in edema after 1 h and maximum analgesia after 30 min from the administration of the formulated sample. SBA-15 mesoporous silica nanoparticle proved to be a very promising drug delivery carrier that can be used as a facile way to enhance the bioavailability of poorly soluble drugs.
Collapse
Affiliation(s)
- Ahmed A Abd-Elrahman
- a Department of Pharmaceutics and Industrial Pharmacy , College of Pharmacy, Cairo University , Cairo , Egypt and
| | - Mohamed A El Nabarawi
- a Department of Pharmaceutics and Industrial Pharmacy , College of Pharmacy, Cairo University , Cairo , Egypt and
| | - Doaa H Hassan
- b Department of Pharmaceutics and Industrial Pharmacy , College of Pharmacy, Misr University for Science and Technology , Sixth of October City, Giza , Egypt
| | - Amal A Taha
- b Department of Pharmaceutics and Industrial Pharmacy , College of Pharmacy, Misr University for Science and Technology , Sixth of October City, Giza , Egypt
| |
Collapse
|
44
|
Preparation and physicochemical characterization of ketoprofen-loaded emulsions. JOURNAL OF PHARMACEUTICAL INVESTIGATION 2016. [DOI: 10.1007/s40005-016-0247-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
45
|
Supercritical impregnation of polymer matrices spatially confined in microcontainers for oral drug delivery: Effect of temperature, pressure and time. J Supercrit Fluids 2016. [DOI: 10.1016/j.supflu.2015.08.023] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
46
|
Petruševska M, Horvat M, Peternel L, Kristan K. High-throughput automated dissolution method applicable for a wide dose range of controlled release pellets. Drug Dev Ind Pharm 2015; 42:1149-57. [DOI: 10.3109/03639045.2015.1117485] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
47
|
Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects. Eur J Drug Metab Pharmacokinet 2015; 41:787-793. [DOI: 10.1007/s13318-015-0313-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
48
|
Yadav NK, Raghuvanshi A, Sharma G, Beg S, Katare OP, Nanda S. QbD-Based Development and Validation of a Stability-Indicating HPLC Method for Estimating Ketoprofen in Bulk Drug and Proniosomal Vesicular System. J Chromatogr Sci 2015; 54:377-89. [DOI: 10.1093/chromsci/bmv151] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2015] [Indexed: 11/13/2022]
|
49
|
Garcia-Arieta A, Gordon J, Gwaza L, Mangas-Sanjuan V, Álvarez C, Torrado JJ. Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets. Mol Pharm 2015; 12:3194-201. [DOI: 10.1021/acs.molpharmaceut.5b00131] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Alfredo Garcia-Arieta
- División
de Farmacología y Evaluación Clínica, Subdirección
de Medicamentos de Uso Humano, Agencia Española de Medicamentos y Productos Sanitarios, 28022 Madrid, Spain
| | - John Gordon
- Division
of Biopharmaceutics Evaluation, Bureau of Pharmaceutical Sciences,
Therapeutic Products Directorate, Health Canada, Ottawa, Ontario K1A 0K9, Canada
| | - Luther Gwaza
- Evaluations
and Registration Division, Medicines Control Authority of Zimbabwe, Harare, Zimbabwe
| | - V. Mangas-Sanjuan
- Pharmacokinetics
and Pharmaceutical Technology Area, Engineering Department, Miguel Hernández University, 03560 San Juan de Alicante, Spain
| | - Covadonga Álvarez
- Farmacia
y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain
| | - Juan J. Torrado
- Farmacia
y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain
| |
Collapse
|
50
|
García-Arieta A, Gordon J, Potthast H. On the Biopharmaceutics Classification System Biowaiver of Ibuprofen. J Pharm Sci 2015; 104:2429-32. [DOI: 10.1002/jps.24519] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2015] [Revised: 05/03/2015] [Accepted: 05/05/2015] [Indexed: 11/11/2022]
|